NCT04170114 Comparison of the Efficacy of Comprehensive Respiratory Physiotherapy in Children With Cystic Fibrosis and Non-Cystic Fibrosis Bronchiectasis Status COMPLETED Phase NA
NCT04166396 Non-pulmonary Contributors of Exercise Intolerance in Patients With Cystic Fibrosis Status COMPLETED Phase EARLY_PHASE1
NCT04161313 Respiratory Function, Exercise Capacity and Peripheral Muscle Strength Among Patients With CF, PCD and Healthy Children Status COMPLETED Phase N/A
NCT04137133 Patienthèque of Finisterian (South of Brittany) Children With Cystic Fibrosis in the Time of Precision Medicine Status RECRUITING Phase NA
NCT04135495 A Phase 2 Study to Evaluate the Safety, Tolerability, PK and PD of ELX-02 in Cystic Fibrosis Patients With G542X Allele Status COMPLETED Phase PHASE2
NCT04126473 A Phase 2 Study to Evaluate the Safety, Tolerability, PK and PD in Cystic Fibrosis Patients With at Least 1 G542X Allele Status COMPLETED Phase PHASE2
NCT04118010 Vitamin D and Prebiotics for Intestinal Health in Cystic Fibrosis Status COMPLETED Phase PHASE4
NCT04114227 Acceptance and Commitment Therapy vs. Supportive Psychotherapy With Cystic Fibrosis Patients Status COMPLETED Phase NA
NCT04105972 A Study Evaluating the Efficacy and Safety of VX-445/Tezacaftor/Ivacaftor in Cystic Fibrosis Subjects, Homozygous for F508del Status COMPLETED Phase PHASE3
NCT04094441 Modeling of Chest Physiotherapy Using Impedance Measurements (PHYSIOMOD) Status COMPLETED Phase NA
NCT04075864 Feasibility of a New Model for Exercise Prescription in Cystic Fibrosis Status COMPLETED Phase NA
NCT04071314 Evaluating the Alimentary and Respiratory Tracts in Health and Disease (EARTH) Research Program. Status UNKNOWN Phase N/A
NCT04059094 A 4-week Study to Test Different Doses of BI 1265162 in Adolescents and Adults With Cystic Fibrosis Using the Respimat® Inhaler - BALANCE - CF™1 Status TERMINATED Phase PHASE2
NCT04058548 Clinical Utility of the 1-minute Sit to Stand Test as a Measure of Submaximal Exercise Tolerance in Patients With Cystic Fibrosis During Acute Pulmonary Exacerbation Status COMPLETED Phase NA
NCT04058366 Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy Status COMPLETED Phase PHASE3
NCT04058353 A Phase 3 Study of VX-445 Combination Therapy in Cystic Fibrosis (CF) Subjects Heterozygous for F508del and a Gating or Residual Function Mutation (F/G and F/RF Genotypes) Status COMPLETED Phase PHASE3
NCT04058210 VX-445/TEZ/IVA Expanded Access Program for Cystic Fibrosis (CF) Patients Heterozygous for F508del Mutation and a Minimal Function Mutation (F/MF Genotypes) Status APPROVED_FOR_MARKETING Phase N/A